Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2014

Open Access 01-12-2014 | Research article

Menstruation associated hypocalcemic symptoms and serum calcium in patients with idiopathic hypoparathyroidism

Authors: Soma Saha, Ravinder Goswami

Published in: BMC Endocrine Disorders | Issue 1/2014

Login to get access

Abstract

Background

Some of the patients with idiopathic hypoparathyroidism (IHP) report symptoms of hypocalcemia during menstruation. There is limited data on this observation.

Methods

Twenty six menstruating women with IHP and 26 healthy controls were questioned regarding symptoms suggestive of hypocalcemia during menstruation. Twelve patients and eight controls were asked to prospectively monitor symptoms suggestive of hypocalcemia and premenstrual syndrome (PMS) if any, over two consecutive menstrual cycles. Serum ionized calcium (SiCa++), total and albumin adjusted calcium and intact paratharmone (iPTH) were measured at eight points covering menstrual, immediate post-menstrual, mid-cycle and premenstrual phase.

Results

Twelve of the 26 (46.2%) patients with IHP reported hypocalcemic symptoms during menstruation as compared to none of the controls. During prospective monitoring, there was no specific trend of hypocalcemic symptoms with respect to the phase of menstrual cycle. The mean SiCa++, serum total and albumin-adjusted calcium, iPTH and inorganic-phosphorus measured over two menstrual cycles were not significantly different in either of the two study groups. None of the subjects had PMS.

Conclusion

Women with IHP do not show any trend of hypocalcemic symptoms or fluctuations in serum calcium over different phases of menstrual cycles. Therefore, patients with hypoparathyroidism linking hypocalcemic symptoms with menstruation should be reassured regarding lack of this association.
Appendix
Available only for authorised users
Literature
1.
go back to reference Shoback D: Clinical practice. Hypoparathyroidism. N Engl J Med. 2008, 359: 391-403. 10.1056/NEJMcp0803050.CrossRefPubMed Shoback D: Clinical practice. Hypoparathyroidism. N Engl J Med. 2008, 359: 391-403. 10.1056/NEJMcp0803050.CrossRefPubMed
2.
go back to reference Goswami R, Brown EM, Kochupillai N, Gupta N, Rani R, Kifor O, Chattopadhyay N: Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism. Eur J Endocrinol. 2004, 150: 9-18. 10.1530/eje.0.1500009.CrossRefPubMed Goswami R, Brown EM, Kochupillai N, Gupta N, Rani R, Kifor O, Chattopadhyay N: Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism. Eur J Endocrinol. 2004, 150: 9-18. 10.1530/eje.0.1500009.CrossRefPubMed
3.
go back to reference Sarin R, Tomar N, Ray D, Gupta N, Sharma YD, Goswami R: Absence of pathogenic calcium sensing receptor gene mutations in sporadic idiopathic hypoparathyroidism. Clin Endocrinol (Oxf). 2006, 65: 359-363. 10.1111/j.1365-2265.2006.02604.x.CrossRef Sarin R, Tomar N, Ray D, Gupta N, Sharma YD, Goswami R: Absence of pathogenic calcium sensing receptor gene mutations in sporadic idiopathic hypoparathyroidism. Clin Endocrinol (Oxf). 2006, 65: 359-363. 10.1111/j.1365-2265.2006.02604.x.CrossRef
4.
go back to reference Tomar N, Bora H, Singh R, Gupta N, Kaur P, Chauhan SS, Sharma YD, Goswami R: Presence and significance of a R110W mutation in the DNA-binding domain of GCM2 gene in patients with isolated hypoparathyroidism and their family members. Eur J Endocrinol. 2010, 162: 407-421. 10.1530/EJE-09-0303.CrossRefPubMed Tomar N, Bora H, Singh R, Gupta N, Kaur P, Chauhan SS, Sharma YD, Goswami R: Presence and significance of a R110W mutation in the DNA-binding domain of GCM2 gene in patients with isolated hypoparathyroidism and their family members. Eur J Endocrinol. 2010, 162: 407-421. 10.1530/EJE-09-0303.CrossRefPubMed
5.
go back to reference Tomar N, Kaushal E, Das M, Gupta N, Betterle C, Goswami R: Prevalence and significance of NALP5 autoantibodies in patients with idiopathic hypoparathyroidism. J Clin Endocrinol Metab. 2012, 97: 1219-1226. 10.1210/jc.2011-3093.CrossRefPubMed Tomar N, Kaushal E, Das M, Gupta N, Betterle C, Goswami R: Prevalence and significance of NALP5 autoantibodies in patients with idiopathic hypoparathyroidism. J Clin Endocrinol Metab. 2012, 97: 1219-1226. 10.1210/jc.2011-3093.CrossRefPubMed
6.
go back to reference Goswami R, Mohapatra T, Gupta N, Rani R, Tomar N, Dikshit A, Sharma RK: Parathyroid hormone gene polymorphism and sporadic idiopathic hypoparathyroidism. J Clin Endocrinol Metab. 2004, 89: 4840-4855. 10.1210/jc.2004-0273.CrossRefPubMed Goswami R, Mohapatra T, Gupta N, Rani R, Tomar N, Dikshit A, Sharma RK: Parathyroid hormone gene polymorphism and sporadic idiopathic hypoparathyroidism. J Clin Endocrinol Metab. 2004, 89: 4840-4855. 10.1210/jc.2004-0273.CrossRefPubMed
7.
go back to reference Tomar N, Gupta N, Goswami R: Calcium-sensing receptor autoantibodies and idiopathic hypoparathyroidism. J Clin Endocrinol Metab. 2013, 98: 3884-3891. 10.1210/jc.2013-2158.CrossRefPubMed Tomar N, Gupta N, Goswami R: Calcium-sensing receptor autoantibodies and idiopathic hypoparathyroidism. J Clin Endocrinol Metab. 2013, 98: 3884-3891. 10.1210/jc.2013-2158.CrossRefPubMed
8.
go back to reference Goswami R, Sharma R, Sreenivas V, Gupta N, Ganapathy A, Das S: Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism. Clin Endocrinol (Oxf). 2012, 77: 200-206. 10.1111/j.1365-2265.2012.04353.x.CrossRef Goswami R, Sharma R, Sreenivas V, Gupta N, Ganapathy A, Das S: Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism. Clin Endocrinol (Oxf). 2012, 77: 200-206. 10.1111/j.1365-2265.2012.04353.x.CrossRef
9.
go back to reference Goswami R, Goel S, Tomar N, Gupta N, Lumb V, Sharma YD: Prevalence of clinical remission in patients with sporadic idiopathic hypoparathyroidism. Clin Endocrinol (Oxf). 2010, 72: 328-333. 10.1111/j.1365-2265.2009.03653.x.CrossRef Goswami R, Goel S, Tomar N, Gupta N, Lumb V, Sharma YD: Prevalence of clinical remission in patients with sporadic idiopathic hypoparathyroidism. Clin Endocrinol (Oxf). 2010, 72: 328-333. 10.1111/j.1365-2265.2009.03653.x.CrossRef
10.
go back to reference Goswami R, Ray D, Sharma R, Tomar N, Gupta R, Gupta N, Sreenivas V: Presence of spondyloarthropathy and its clinical profile in patients with hypoparathyroidism. Clin Endocrinol (Oxf). 2008, 68: 258-263. Goswami R, Ray D, Sharma R, Tomar N, Gupta R, Gupta N, Sreenivas V: Presence of spondyloarthropathy and its clinical profile in patients with hypoparathyroidism. Clin Endocrinol (Oxf). 2008, 68: 258-263.
11.
go back to reference Goswami R, Marwaha RK, Goswami D, Gupta N, Ray D, Tomar N, Singh S: Prevalence of thyroid autoimmunity in sporadic idiopathic hypoparathyroidism in comparison to type 1 diabetes and premature ovarian failure. J Clin Endocrinol Metab. 2006, 91: 4256-4259. 10.1210/jc.2006-1005.CrossRefPubMed Goswami R, Marwaha RK, Goswami D, Gupta N, Ray D, Tomar N, Singh S: Prevalence of thyroid autoimmunity in sporadic idiopathic hypoparathyroidism in comparison to type 1 diabetes and premature ovarian failure. J Clin Endocrinol Metab. 2006, 91: 4256-4259. 10.1210/jc.2006-1005.CrossRefPubMed
12.
go back to reference Aggarwal S, Kailash S, Sagar R, Tripathi M, Sreenivas V, Sharma R, Gupta N, Goswami R: Neuropsychological dysfunction in idiopathic hypoparathyroidism and its relationship with intracranial calcification and serum total calcium. Eur J Endocrinol. 2013, 168: 895-903. 10.1530/EJE-12-0946.CrossRefPubMed Aggarwal S, Kailash S, Sagar R, Tripathi M, Sreenivas V, Sharma R, Gupta N, Goswami R: Neuropsychological dysfunction in idiopathic hypoparathyroidism and its relationship with intracranial calcification and serum total calcium. Eur J Endocrinol. 2013, 168: 895-903. 10.1530/EJE-12-0946.CrossRefPubMed
13.
go back to reference Goswami R, Bhatia M, Goyal R, Kochupillai N: Reversible peripheral neuropathy in idiopathic hypoparathyroidism. Acta Neurol Scand. 2002, 105: 128-131. 10.1034/j.1600-0404.2002.1c031.x.CrossRefPubMed Goswami R, Bhatia M, Goyal R, Kochupillai N: Reversible peripheral neuropathy in idiopathic hypoparathyroidism. Acta Neurol Scand. 2002, 105: 128-131. 10.1034/j.1600-0404.2002.1c031.x.CrossRefPubMed
14.
go back to reference McCullagh EP, Kearns JE: The relationship between the parathyroid glands and sex hormones in tetany. Endocrinology. 1953, 19: 532-542.CrossRef McCullagh EP, Kearns JE: The relationship between the parathyroid glands and sex hormones in tetany. Endocrinology. 1953, 19: 532-542.CrossRef
15.
go back to reference Wijnbladh H: Postoperative tetany; a study based upon 40 treated cases. Acta Endocrinologica (Copenh). 1952, 10: 1-16. Wijnbladh H: Postoperative tetany; a study based upon 40 treated cases. Acta Endocrinologica (Copenh). 1952, 10: 1-16.
16.
go back to reference Ellison RR, Kantrowitz AR, Norsa L, Perlmutter M: Idiopathic hypoparathyroidism and Addison’s disease. Am J Med. 1956, 21: 634-643. 10.1016/0002-9343(56)90078-X.CrossRefPubMed Ellison RR, Kantrowitz AR, Norsa L, Perlmutter M: Idiopathic hypoparathyroidism and Addison’s disease. Am J Med. 1956, 21: 634-643. 10.1016/0002-9343(56)90078-X.CrossRefPubMed
17.
go back to reference Davis RH, Fourman P, Smith JW: Prevalence of parathyroid insufficiency after thyroidectomy. Lancet. 1961, 2: 1432-1435.CrossRefPubMed Davis RH, Fourman P, Smith JW: Prevalence of parathyroid insufficiency after thyroidectomy. Lancet. 1961, 2: 1432-1435.CrossRefPubMed
18.
go back to reference Burckhardt P, Ruedi B, Felber JP: Estrogen-induced tetany in idiopathic hypoparathyroidism. Horm Res. 1975, 6: 321-328. 10.1159/000178681.CrossRefPubMed Burckhardt P, Ruedi B, Felber JP: Estrogen-induced tetany in idiopathic hypoparathyroidism. Horm Res. 1975, 6: 321-328. 10.1159/000178681.CrossRefPubMed
19.
go back to reference Graham WP, Gordon GS, Loken HF, Blum A, Halden A: Effect of pregnancy and of the menstrual cycle on hypoparathyroidism. J Clin Endocrinol Metab. 1964, 24: 512-516. 10.1210/jcem-24-6-512.CrossRefPubMed Graham WP, Gordon GS, Loken HF, Blum A, Halden A: Effect of pregnancy and of the menstrual cycle on hypoparathyroidism. J Clin Endocrinol Metab. 1964, 24: 512-516. 10.1210/jcem-24-6-512.CrossRefPubMed
20.
go back to reference Mallette LE: Case report: hypoparathyroidism with menses-associated hypocalcemia. Am J Med Sci. 1992, 304: 32-37. 10.1097/00000441-199207000-00009.CrossRefPubMed Mallette LE: Case report: hypoparathyroidism with menses-associated hypocalcemia. Am J Med Sci. 1992, 304: 32-37. 10.1097/00000441-199207000-00009.CrossRefPubMed
21.
go back to reference ACOG Practice Bulletin: Number 15, April 2000. Premenstrual syndrome. Clinical management guidelines for obstetrician-gynecologists. ACOG Practice Bulletin: Number 15, April 2000. Premenstrual syndrome. Clinical management guidelines for obstetrician-gynecologists.
Metadata
Title
Menstruation associated hypocalcemic symptoms and serum calcium in patients with idiopathic hypoparathyroidism
Authors
Soma Saha
Ravinder Goswami
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2014
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/1472-6823-14-28

Other articles of this Issue 1/2014

BMC Endocrine Disorders 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.